Introduct ion
Mucosal me lanomas were first described by Weber in 1859.
1 Primary sinonasal malignant melanoma is a rare lesio n, with a reported annua l incidence of 0.0 18 per 100,000 population.' Mucosal malignant melanoma has a different clinical course and outcome than its cutaneous counterpart. Sinonasal ma lignant me lanoma, in turn, has a different clinical course and outcome than malignant melanoma in other mucosal sites.?" For example, sinonasal malignant melanoma has a more aggressive behavior and is associated with a poorer prognosis than oral cavity me lanoma despite aggressive surgical treatment and postoperative irradiation. The poorer outcomes may be attributable to difficulties in dete cting sinonasal tumors. The rela -. tive inaccessibility of the mucosa to self-examination often delays diagnosis. Also, morbidity and mortality may be increased as a result of the proximity of these tumors to vital structures such as the orbit and brain. The differential diagnosis should include carcinoma, lymphoma, sarcoma, and olfactory neuroblastoma.
Because of the small number of primary sinonasal malignant mel anomas tha t have been reported in the literature, littl e new inform ation has been generated about this entity, and treatments have var ied over the years. In this article, we describe our retrospective study of the clinicopathologic features of and prognostic factors associated with cases of primary sinonasal malignant melanoma that were managed at our institution.
Pat ients and met hods
We reviewed the medical records of all patients who had been treated for primary head and neck malignant me lanoma at our institution between Janu ary 1996 and December 2004. We found 90 such cases. All patients had undergone clinical examination of the neck and www.entjourna l.com • 1269 abdo men, nasal endosc opy to determin e th e extent of th e tumor, and contras t-enhanced computed tomograph y of th e nose, paranasal sinuses, and neck. Magnetic reso nance imaging had been pe rformed in those patients who had been suspected of having intracranial extension. All patients ha d undergone ultrasonography of the abdomen and a bon e scan to look for distant me tastases .
We then narrowed our populatio n to those who had presented with a primary malignant melanoma of the nasal cavity or paranasal sinuses. Patients with ocular melanoma that had extended into the nasal cavity were not included in our ana lysis. The primary nature of the presenting sino nasal malignant melanoma had been confirmed by clinical data -specifically, (1) the absence of a history of melanoma at any other site in the body an d (2) an abse nce of evidence of a metastatic melano ma from an extramucosa l site. In all, 10 patients-7 men and 3 wome n, aged 35 to 70 years (mean: 51.4)-me t our inclu sion criteria.
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In addition to dem ograph ic dat a, we compiled information on presentin g symptoms, the site of the primary tu mor, th e presence of any nodal or distant metastasis at presentation, the tumor stage, initi al treatment , follow-up, any seque la (postoperative recurrence or metastasis) and its tr eatment, outcomes, and histopathologic features.
Presentingfeatu res.The pr esentin g symptoms were nasal obstruction in 6 patients, epistaxis in 2, epiphor a in 2, neck swelling in 2, and diplopi a with a decrease in vision in 1. The primary tumor was seen in the nasal cavity in 7 patients and in a paranasal sin us in 3 (2 maxillary sinus and 1 ethmoid sinus) . Two patient s presented with a neck node metastasis and 1with a liver metastasis. Six pa tients had a clinical stage I tumor, 2 had a stage II tumor, and 1 pati ent each had a stage III and IV tumor (tab le) .
Initial treatm ent. Nin e pat ients had undergone surgical excision of the primary tumor-7 via an external approach and 2 via an endoscopic approach. The remaining patient (patient 5), who had presented with a liver metastasis, received chemotherapy and palliative local radiotherapy. The 7 external procedures included a medial maxillectomy in 4 patients and wide local excision in 3 patients (table) .
The 2 patients who had a lymph node metastasis at presentation also underwent neck dissection concurrently with excision of the primary tumor.
Follow-up. Patients were kept on a regular follow-up sched ule after treatment. Follow-up ranged from 8 to 70 months (median: 25) (table) . Total follow-up was calculated in month s from the date of diagnosis to the last recorded enco unter.
Sequelae. Following initial surgery, 3 patients developed a local recurrence, 2 developed a neck node metastasis,and 4 developed a distan t metastasis (21ung, 1 spinal cord, and 1 liver). The local recurrences were treated with endoscopic and wide excision, the neck node metastases with neck dissect ion, and the distant metastases with chemotherapy. In addition to the 1 patient who presented with a liver metastasis and who received palliative local radiotherapy (patient 5), 6 pat ients received postoperative rad iotherapy-3 for a local recurrence, 2 for a nodal metastasis, and 1 for a spinal cord metastasis.
In addition to patient 5,3 patients receivedpostoperative chemotherapy with dacarbazine for the treatment of a dista nt metastasis-2 for a lung metastasis and 1 for a liver metastasis. The patient who developed a spinal cord metastasis (patient 3) did not receive chemotherapy.
Results
At the final follow-up, 4 of the 10patients were aliveand without disease (tab le). Overall 2-and 5-year survival rates were 60 and 40%, respectively. The 4 survivors at the last follow-up-i-S men and 1 woman-ranged in age from 35 to 60 years (mean: 47.0) . The 6 pat ients who died included 4 men and 2 women; their ages ranged from 41 to 70 years (mean: 54.3)
Presenting [eatures. Two of the 3 pat ients (67%) who presented with a paranasal sinus melanoma died, compared with4of7patients (57%) who hada pr imary nasal cavity tumor.
Ofthe 2 patients who presented with a neck node metastasis, 1 was alive at 36 months. The other developed a spina l cord metastasis postoperatively, and he died 12 months after diagnosis. The patient who presented with a liver metas tasis died 8 mo nths later.
Three of the 6 patients who presented with a stage I tumor and 1 of the 2 who prese nted with a stage II tumor were still alive by the last follow-up. In contrast, the patients with stage III and stage IV disease both died 8 months after diagnosis.
In itial treat ment. Three of the 4 patients who underwent medial maxillectomy survived to the last follow-up. However, 2 of the survivors subseq uently developed a local recurrence and 1 developed a neck node metastasis. The patient who died had a liver metastasis.
Of the 2 patients who underwent endoscopic excision, 1 died at 12 months of a spinal cord metas tasis, and 1 was alive at 70 months. However, the survivor did develop a postoperative local recurrence.
None of the 3 patie nts who underwent wide local excision survived. One developed a neck node metastasis and died at 30 months , and 2 developed a lung metastasis and died at 8 and 26 months.
Sequelae.All 3 patie nts who developed a postoperative local recurrence were alive at the last follow-up . Of Volume 88, Number 12
www.entjourn al.com · 1271 th e 2 patients who developed a neck node metastasis postoperatively, 1 was alive at 24 months and the other died at 30 months. All 4 patients who develop ed a distant metastasis postop eratively died within 26 months of diagnosis (mean: 15; median 13). Radiotherapy. Of the 5 pati ent s who had received a radical dose of radiation (50 Gy), 4 were alive at the last follow-up. Pati ent 3 received onl y 30 Gy.
Chemotherapy. All 4 patients who received chemotherapy died within 26 months (mean: 14).
Histopathology. Th ere was a cons iderable difference in the number of diseased neck nodes seen on histopathology (range: 10 to 20; mean: 15) compared with the number dete cted on palpation (mean: 2).
Discussion
The 5-year sur vival rate of 40% in our study is comparable to th e rates in studies reported by Snow et al 6 (38%) and Manolidis and Donald?(30%). The primary indicator of a poo r prognosis in our study was a distant metastasis.All 5 patients with a distant metastasis died within 26 months despite adequate locoregional control in most cases. This findi ng confirms th e aggressive nature of this disease. None of the 4 sur vivors had a distant met astasis, and only 1 patient without a distant metastasis had died during follow-up.
Other possibly poor prognostic factors included (1) older age, (2) a primary tumor location in a paran asal sinus, (3) an advanced tumor stage, (4) an extern al approach to surgery, and (5) the absence of adju vant rad iotherapy.
. Th e mean age of the patients in ou r study (51.4 . yr) is consistent with th at reported by oth ers in the literature.v? Also, th e ' male preponderan ce and the disease pr edilection for patients older th an 50 years (n = 7) in our study population has been noted in oth er series.":" For many reason s, including better immunosurveillance and a less virulent form of melan om a, younger patient s generally have a better pr ogno sis. Th e site of the pr im ary tumor might also have been a pro gnostic factor, as 67% of those with a paran asal sinus melanoma died, compared with 57% of tho se who had a nasal cavity tumor.
Th e expected association between tumo r stage at diagnosis and outcomes was seen in our study.
Inall,4 pati ent s experienced a neck node metastasis. Two of these were pr esent at diagnosis, and 2 oth ers occurred postop eratively. In both circumstances, 1 patient died during follow-up and 1 remained alive at th e last follow-up (table) .
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Of the 2 patients who underwent endos copic excision, 1 experienced a recur rence and the other a spinal cord met astasis.
Four of the 6 patients who received postoperative radiotherapy were alive at the last follow-up. The 3 patients who did not undergo adjuvant irr adiation all died of a distant metastasis.
Despite aggressive sur gical tre atment and postoperative radio-and chemotherapy, primary sino nasal malignant melan oma carries a poor pro gnosi s. All 9 patien ts who were aggressively treated developed either a recurrence or a local or distant metastasis.
On e of the drawba cks of th is study obviously is the small size of the patient sample , which pr ecluded us from identifying statistically significant differences. However, 'in view of the paucity of literature on sinonasal malignant melanomas, we hope th at our observations will serve to add to our knowledge of thi s disease, its treatment, and its prognosis.
